Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VRML

Vermillion (VRML) Stock Price, News & Analysis

Vermillion logo

About Vermillion Stock (NASDAQ:VRML)

Advanced Chart

Key Stats

Today's Range
$0.15
$0.17
50-Day Range
$2.54
$4.24
52-Week Range
$0.35
$5.78
Volume
34,062 shs
Average Volume
440,144 shs
Market Capitalization
$17.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VRML Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vermillion and its competitors with MarketBeat's FREE daily newsletter.

VRML Stock News Headlines

Camellia Vermillion
Dr. Richard L. Knutson
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Vermillion Elementary School
Dr. Kenneth J. Vermillion
Vermillion High School
Sanford Vermillion Medical Center
See More Headlines

VRML Stock Analysis - Frequently Asked Questions

Vermillion, Inc. (NASDAQ:VRML) issued its quarterly earnings data on Thursday, August, 8th. The company reported ($0.06) EPS for the quarter. The business had revenue of $1.14 million for the quarter. Vermillion had a negative net margin of 307.31% and a negative trailing twelve-month return on equity of 155.25%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vermillion investors own include CombiMatrix (CBMX), Accelerate Diagnostics (AXDX), Himax Technologies (HIMX), Charter Communications (CHTR), Idera Pharmaceuticals (IDRA), Magnachip Semiconductor (MX) and Cardiff Oncology (TROV).

Company Calendar

Last Earnings
8/08/2019
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
NASDAQ:VRML
CIK
926617
Fax
N/A
Employees
43
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.24 million
Net Margins
-307.31%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.54 million
Price / Cash Flow
N/A
Book Value
$0.09 per share
Price / Book
1.94

Miscellaneous

Free Float
N/A
Market Cap
$17.00 million
Optionable
Not Optionable
Beta
3.47
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:VRML) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners